Brief: Biophytis Announces Transfer Of ADSs To OTC Market
24/04/2024 22:02
April 24 (Reuters) - Biophytis SA ALBPS.PA :
* BIOPHYTIS ANNOUNCES TRANSFER OF ADSS TO OTC MARKET
* ADSS DELISTED FROM NASDAQ, WHICH WILL RESULT IN MEANINGFUL
SAVINGS
* ADSS TRANSFERRED TO OTC PINK MARKET; COMPANY WILL APPLY TO
TRADE
ON OTCQB MARKET
Source text for Eikon: ID:nEQ1F1QZfa
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon